d

dNovo Inc

2 employees

Dnovobio is a developer of a direct reprogramming technology intended to create any cell, tissue, or organ on demand.

Basic info

Industry

medical equipment manufacturing

Sectors

Biotechnology
Health Care
Medical

Date founded

2018

Funding rounds raised

Total raised

$2.7M

from 4 investors over 4 rounds

d

dNovo Inc raised $2.7M on January 24, 2022

Investors: Pioneer Fund, Y Combinator and Soma Capital

d

dNovo Inc raised undisclosed on January 1, 2018

Investors: Soma Capital

FAQ